UPClytics

Amgen NV

Operating company

Corporate group: Amgen Group · HQ: United States

Total cases
2
Claimant-side
1
Respondent-side
1

Not counted above: 1 file-access request (R. 262.1(b) RoP), where someone asked to read a case file. View

Amgen NV has been party to two Unified Patent Court cases, once as claimant and once as respondent. The most recent on record is UPC CoA 153/2026 at the Court of Appeal, brought by Carpmaels & Ransford LLP. Its most recent decision on the merits was in UPC CFI 505/2023 at the Dusseldorf Local Division on 13 May 2025: no infringement found.

Top opponents
  • Regeneron Pharmaceuticals Inc.2

More opponents

Top firms
  • Bardehle Pagenberg2

More firms

Start 14-day free trialEvery opponent and every firm acting for and against Amgen NV.Already a user? Sign in
Recent cases
View all cases
  • 2026-09-15UPC CoA 153/2026File-access requestCarpmaels & Ransford LLP v Amgen Zdravila D.O.O.
  • 2025-07-11UPC CoA 646/2025WithdrawnAmgen NV v Regeneron Pharmaceuticals Inc.
  • 2024-01-10UPC CFI 505/2023No infringementSanofi Biotechnology SAS v Amgen Inc.